To Study The Scope & Importance Of Amended Patent Act On Indian Pharmaceutical Company With Respect To Innovation
-
Judge Finds Biosimilar Patent Procedures Optional – Courtesy (Pharma Patent)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 23 MARCH 2015POSTED IN BIOSIMILARSJudge Seeborg of the U.S. District Court for the Northern District of...
-
Maximizing Use of the USPTO’s Patent Application Alert Service
Pharma Live, , Intellectual Property Rights, 0
The U.S. Patent and Trademark Office (USPTO) recently launched the Patent Application Alert Service (PAAS), a free electronic tool aimed to...
-
Pluristem Therapeutics Inc Granted European Patent For Use Of Cells To Help Treat Damaged Bone Marrow – Courtesy (Biospace)
Pharma Live, , Intellectual Property Rights, 0
Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, announced that it has been issued...
-
Why orphan drug coverage reimbursement decision-makingneeds patient and public involvement
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0168851015000123-mainDownload
-
Suven Life Sciences gets patents for neurological drug
Pharma Live, , Intellectual Property Rights, 0
Suven Life Sciences gets patents for neurological drug
-
The relationship between a firm’s patent quality and its market value — The case of US pharmaceutical industry
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0040162509000791-mainDownload
-
The Importance of Contracts for Joint Infringement in Patent Cases – Courtesy (IP Litigation Current)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY JUSTIN M. SOBAJE ON 19 MAY 2015POSTED IN DIVIDED INFRINGEMENT;DIVIDED INFRINGEMENT;PATENTS;PLEADINGS;SUPREME COURTIt has been about a year since the Supreme...
-
Novartis Patent Application Rejected in India!
Pharma Live, , Intellectual Property Rights, 0
NOVARTIS spent nearly 15 years seeking a patent in India for Glivec, a medicine for chronic myeloid leukemia. That...